The modern trends in prevention and pharmacotherapy of thrombotic and thrombembolic diseases is the main topics of this revuew. New anticoagulant groups, namely direct thrombin inhibitiors, direct f.
Xa inhibitors, new pentasacharides and new vitamin K antagonists are discussed